BioTelemetry (NASDAQ: BEAT) reported Q1 EPS of $0.16, in-line with the analyst estimate of $0.16. Revenue for the quarter came in at $55.9 million versus the consensus estimate of $55.57 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.